Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative biolabs has developed Lentiviral CAR vector pCDCAR1 EBV gp42 (X9X156) h(28BB_), which is constructed for the engineering of T cells to target human EBV gp42. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-EBV gp42 antibody linked to a CD28 transmembrane domain/ endodomain and CD137 (4-1BB), CD3-zeta signaling domains. And the vector product was designed for the treatment of Pancreatic cancer.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.